Individualized Infiximab Dosing-Proof of Concept Study

Clinical trial NCT02027727 · UNKNOWN

Trial details

NCT number: NCT02027727
Sponsor: Cedars-Sinai Medical Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Inflammatory Bowel Diseases

Start date: 2013-11-01
Primary completion: 2017-05-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.